BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.
about
The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancerMicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
P2860
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@ast
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@en
type
label
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@ast
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@en
prefLabel
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@ast
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@en
P2093
P2860
P356
P1433
P1476
BCL9, a coactivator for Wnt/β- ...... h prostate cancer progression.
@en
P2093
Fu-Neng Jiang
Guan-Xing Chen
Hong-Wei Luo
Wei-DE Zhong
Xiao-Hui Ling
Ying-Ke Liang
Ze-Zhen Liu
Zhi-Yun Chen
P2860
P304
P356
10.3892/OL.2016.4161
P577
2016-01-29T00:00:00Z